Some of the program's offerings include yoga, mentoring and Christian devotionals.

The trial will compare the safety and efficacy of equecabtagene autoleucel versus standard therapies in r/r MM patients.

Taiwan's famous tea industry produces a lot of bio-waste. One enterprising group is turning that into eco-friendly cat litter ...

Bio Green Med Solution, Inc. ("BGMS," the "Company" or “we,” formerly Cyclacel Pharmaceuticals, Inc.) (NASDAQ: BGMS), a ...

Q4 2025 Earnings Call March 30, 2026 4:30 PM EDTCompany ParticipantsDaniel Carlson - Head of Investor RelationsDavid Moss ...

Against the backdrop of volatility in the global fertilizer market, Pivot Bio today announced a new multiyear nitrogen price and supply assurance program designed to help farmers lock in nitrogen ...

As West Asia tensions strain energy supplies, industry backs bio-isobutanol blending in diesel to boost energy security without affecting mileage, using existing distilleries with minimal investment ...

Amicus Brief Addresses PTAB Review of Obviousness-Type Double Patenting and Patent Term Issues Affecting Biotech ...

Pro-forma cash and investment balance of $530.2 million as of December 31, 2025 expected to provide runway into early 2029 BOSTON, March 30, 2026 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a ...

Q32 Bio is now largely a single-asset story centered on Bempikibart in alopecia areata, with mid-2026 topline data as the key catalyst. See why QTTB stock is a Buy.

Can tiny biological production factories ever give petrochemicals or animals a run for their money? 21st Bio weighs ...

BOSTON, March 30, 2026 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced the dosing of the first ...